Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.

The Kaohsiung Journal of Medical Sciences
Zhi-Feng LiuYong-Qian Gong

Abstract

The roles of RNA m6A modification in carcinogenesis have attracted much interest recently. However, the dysregulation of RNA m6A regulators (writers, readers, and erasers) in nasopharyngeal carcinoma (NPC) has never been reported. In this study, we showed that METTL3, one of the writers, was upregulated in NPC. Functional studies revealed that METTL3 promoted the migration and invasion of NPC cells. However, METTL3 knockdown reversed this effect and inhibited the migration, invasion and metastasis of NPC cells. METTL3 activated the luciferase activity of TOPflash (a reporter for beta-catenin/TCF signaling), and downregulation of METTL3 inhibited the expression of beta-catenin/TCF target genes vimentin and N-cadherin, which are two regulators of epithelial-mesenchymal transition. Moreover, dominant negative beta-catenin blocked the migration and invasion of NPC cells. Further mechanistic studies showed that METTL3 silencing decreased the m6A methylation and total mRNA levels of Tankyrase, a negative regulator of axin. Moreover, Tankyrase overexpression abrogated the repressive effects of METTL3 silencing on the migration of NPC cells. Collectively, our study demonstrates the oncogenic roles of METTL3 in NPC, and suggests that ME...Continue Reading

References

May 4, 2002·Nature Reviews. Molecular Cell Biology·Mariann Bienz
Sep 18, 2009·Nature·Shih-Min A HuangFeng Cong
Apr 28, 2016·Molecular Cell·Shuibin LinRichard I Gregory
Nov 20, 2016·Biochemical and Biophysical Research Communications·Minjun DuYushun Gao
May 5, 2017·Journal of Animal Science and Biotechnology·Xiaoxu ChenWenxian Zeng
May 14, 2017·Trends in Genetics : TIG·Jean-Yves Roignant, Matthias Soller
Jun 1, 2017·World Journal of Clinical Cases·Malvine VogelYassine Lalami
Jun 24, 2017·Genes & Development·Nicolle A Rosa-MercadoJoan A Steitz
Nov 7, 2017·Trends in Cell Biology·Deepak P PatilSamie R Jaffrey
Nov 25, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mengnuo ChenChun-Ming Wong
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 6, 2018·Cell Stem Cell·Gaëlle H Martin, Christopher Y Park
Mar 29, 2018·Journal of Hematology & Oncology·Yutian PanYongqian Shu
Mar 25, 2019·Biochemical and Biophysical Research Communications·Jie LiBaolan Li

❮ Previous
Next ❯

Citations

Apr 22, 2021·Biomarker Research·Yiqing CaiXin Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.